# Novartis Pharmaceuticals Corporation – FDA Inspection, Nov 18, 2008

Source: https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corporation/93726160-4eff-41ad-9590-fcf40a3560ee
Source feed: FDA_Inspections

> FDA inspection 548913 of Novartis Pharmaceuticals Corporation, November 18, 2008. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. 30 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 548913
- Company Name: Novartis Pharmaceuticals Corporation
- Inspection Date: 2008-11-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1328008 - 2026-06-24
- [FDA Inspection 1276202 - 2025-06-25](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corporation/d76eeb82-f498-4fa6-9c50-25c0625a0d59)
- FDA Inspection 1263198 - 2025-03-03
- FDA Inspection 1257911 - 2024-11-19
- [FDA Inspection 1248433 - 2024-08-29](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corporation/ccf044c3-0b3e-481e-97b9-66c1a8ca3e62)

Company: https://www.keypedia.com/companies/novartis-pharmaceuticals-corporation/aa4c85c1-794a-407a-8eb3-8802c196795b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c